Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement

References

• Albert V, Klein D, Noble A, Zahand E, Holtby S. Identifying substance abusing delivering women: consequences for child maltreatment reports. Child Abuse Negl 2000;24:173–183.
   PubMed Web of Science ®Google Scholar
• Jaudes PK, Ekwo E, Van Voorhis J. Association of drug abuse and child abuse. Child Abuse Negl 1995;19:1065–1075.
   PubMed Web of Science ®Google Scholar
• Arria AM, Derauf C, Lagasse LL, Grant P, Shah R, Smith L, Haning W, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J 2006;10:293–302.
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88:F98–F100.
   PubMed Web of Science ®Google Scholar
• Derauf C, Katz AR, Frank DA et al. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. Journal of Drug Issues 2003;33:1001–1016.
   Google Scholar
• Greenfield SF, Manwani SG, Nargiso JE. Epidemiology of substance use disorders in women. Obstet Gynecol Clin North Am 2003;30:413–446.
   PubMed Web of Science ®Google Scholar
• Mulvihill AO, Cackett PD, George ND, Fleck BW. Nystagmus secondary to drug exposure in utero. Br J Ophthalmol 2007;91:613–615.
   PubMed Web of Science ®Google Scholar
• Child Abuse in Iowa: 2009 [cited 2011 April 10]. Avalible from:URL: http://www.pcaiowa.org/child_abuse.html.
   Google Scholar
• Iowa Alliance for Drug Endangered Children: 2009 [cited 2011 April 10]. Avalibe from:URL: http://www.iowadec.net/.
   Google Scholar
• Iowa Drug Trends: 2009 [cited 2011 April 10]. Avalible from:URL: http://www.iowa.gov/odcp/docs/iowadrugtrends062209.pdf.
   Google Scholar
• National Survey on Drug Use and Health Report. Substance use treatment among women of childrearing age: 2007 [cited 2011 April 10]. Avalible from:URL: http://www.oas.samhsa.gov/factsNSDUH.htm#2k7Pubs.
   Google Scholar
• Chasnoff IJ, McGourty RF, Bailey GW, Hutchins E, Lightfoot SO, Pawson LL, Fahey C, et al. The 4P’s Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005;25:368–374.
   PubMedGoogle Scholar
• El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylack L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol 2003;23:354–360.
   PubMedGoogle Scholar
• Ondersma SJ, Simpson SM, Brestan EV, Ward M. Prenatal drug exposure and social policy: the search for an appropriate response. Child Maltreat 2000;5:93–108.
   PubMedGoogle Scholar
• Bauer CR, Shankaran S, Bada HS, Lester B, Wright LL, Krause-Steinrauf H, Smeriglio VL, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002;186:487–495.
   PubMed Web of Science ®Google Scholar
• Buchi KF, Varner MW, Chase RA. The prevalence of substance abuse among pregnant women in Utah. Obstet Gynecol 1993;81:239–242.
   PubMedGoogle Scholar
• Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003;101:374–379.
   PubMed Web of Science ®Google Scholar
• O’Connor TA, Bondurant HH, Siddiqui J. Targeted perinatal drug screening in a rural population. J Matern Fetal Med 1997;6:108–110.
   PubMedGoogle Scholar
• Sloan LB, Gay JW, Snyder SW, Bales WR. Substance abuse during pregnancy in a rural population. Obstet Gynecol 1992;79:245–248.
   PubMed Web of Science ®Google Scholar
• Statistics on Pregnant Women’s Illicit Drug Use: 2002 [cited 2009 January 8]. Avalible from:URL: http://ncadistore.samhsa.gov/catalog/facts.aspx?topic=11.
   Google Scholar
• Adirim TA, Sen Gupta N. A national survey of state maternal and newborn drug testing and reporting policies. Public Health Rep 1991;106:292–296.
   PubMed Web of Science ®Google Scholar
• Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990;322:1202–1206.
   PubMed Web of Science ®Google Scholar
• Greene DL. Abusive prosecutors: race and class discretion and the prosecution of drug-addicted mothers. Buffalo Law Rev 1991;39:737–802.
   PubMedGoogle Scholar
• Hans SL. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol 1999;26:55–74.
   PubMed Web of Science ®Google Scholar
• MacMahon JR. Perinatal substance abuse: the impact of reporting infants to child protective services. Pediatrics 1997;100:E1.
   PubMedGoogle Scholar
• Stoler JM, Holmes LB. Under-recognition of prenatal alcohol effects in infants of known alcohol abusing women. J Pediatr 1999;135:430–436.
   PubMed Web of Science ®Google Scholar
• Little BB, Snell LM, Rosenfeld CR, Gilstrap LC 3rd, Gant NF. Failure to recognize fetal alcohol syndrome in newborn infants. Am J Dis Child 1990;144:1142–1146.
   PubMedGoogle Scholar
• Bibb KW, Stewart DL, Walker JR, Cook VD, Wagener RE. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews. J Perinatol 1995;15:199–202.
   PubMedGoogle Scholar
• Day NL, Cottreau CM, Richardson GA. The epidemiology of alcohol, marijuana, and cocaine use among women of childbearing age and pregnant women. Clin Obstet Gynecol 1993;36:232–245.
   PubMed Web of Science ®Google Scholar
• Frank DA, Zuckerman BS, Amaro H, Aboagye K, Bauchner H, Cabral H, Fried L, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics 1988;82:888–895.
   PubMed Web of Science ®Google Scholar
• Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001;107:309–317.
   PubMed Web of Science ®Google Scholar
• Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987;111:571–578.
   PubMed Web of Science ®Google Scholar
• Ostrea EM Jr, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V, Ager J. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001;138:344–348.
   PubMed Web of Science ®Google Scholar
• Schutzman DL, Frankenfield-Chernicoff M, Clatterbaugh HE, Singer J. Incidence of intrauterine cocaine exposure in a suburban setting. Pediatrics 1991;88:825–827.
   PubMed Web of Science ®Google Scholar
• Oral R, Strang T. Neonatal illicit drug screening practices in Iowa: the impact of utilization of a structured screening protocol. J Perinatol 2006;26:660–666.
   PubMedGoogle Scholar
• Zellman GL, Fair C, Houbé J, Wong M. A search for guidance: examining prenatal substance exposure protocols. Matern Child Health J 2002;6:205–212.
   PubMedGoogle Scholar
• Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics 1993;92:396–402.
   PubMed Web of Science ®Google Scholar
• Zellman GL, Jacobson PD, Bell RM. Influencing physician response to prenatal substance exposure through state legislation and work-place policies. Addiction 1997;92:1123–1131.
   PubMedGoogle Scholar
• Berger L, Waldfogel J. Prenatal cocaine exposure: Long-run effects and policy implications. Social Service Review 2000; 74:28–54.
   Google Scholar
• Dore MM, Doris JM, Wright P. Identifying substance abuse in maltreating families: a child welfare challenge. Child Abuse Negl 1995;19:531–543.
   PubMed Web of Science ®Google Scholar